CDK12 gene inactivation: Study defines key driver of aggressive ovarian cancer

A new study explains the genetic underpinnings of a rare and aggressive form of ovarian cancer—and offers a potential pathway for new treatments.

Leave A Comment

Your email address will not be published. Required fields are marked *